Similarly, NUSAP1 and NCAPG stimulate the progression of NSCLC by controlling the BTG2/PI3K/Akt signaling pathway and upregulating LGALS1 expression [58,59]. The gene discussed is BTG2; the disease is non-small cell lung carcinoma.